69
Participants
Start Date
March 16, 2017
Primary Completion Date
May 2, 2023
Study Completion Date
May 2, 2023
Leuprolide acetate
A subset of premenopausal women will receive GnRHAG (leuprolide acetate) 3.75 mg/mo by intramuscular injection every 4 weeks for 24 weeks (6 doses).
University of Colorado Anschutz Medical Campus, Aurora
University of Ottawa
OTHER
Université de Sherbrooke
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Colorado, Denver
OTHER